Adynxx Earnings Calls

Sep 30, 2019
Release date Nov 14, 2019
EPS estimate -
EPS actual -$0.330
Revenue estimate -
Revenue actual -
Jun 30, 2019
Release date Aug 14, 2019
EPS estimate -
EPS actual -$0.86
Revenue estimate -
Revenue actual -
Mar 31, 2019
Release date Apr 23, 2019
EPS estimate -
EPS actual -$1.32
Revenue estimate -
Revenue actual 129K
Dec 31, 2018
Release date Feb 22, 2019
EPS estimate -
EPS actual -$1.55
Revenue estimate -
Revenue actual 460K

Last 4 Quarters for Adynxx

Below you can see how ADYX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Dec 31, 2018
Release date Feb 22, 2019
Price on release $
EPS estimate -
EPS actual -$1.55
Date Price
Sep 20, 2021 $0.0426
Sep 21, 2021 $0.0218
Sep 22, 2021 $0.0205
Sep 23, 2021 $0.0245
4 days before -100.00%
4 days after 0%
On release day 0%
Change in period -42.49%
Mar 31, 2019
Release date Apr 23, 2019
Price on release $
EPS estimate -
EPS actual -$1.32
Date Price
Sep 20, 2021 $0.0426
Sep 21, 2021 $0.0218
Sep 22, 2021 $0.0205
Sep 23, 2021 $0.0245
4 days before -100.00%
4 days after 0%
On release day 0%
Change in period -42.49%
Jun 30, 2019
Release date Aug 14, 2019
Price on release $
EPS estimate -
EPS actual -$0.86
Date Price
Sep 20, 2021 $0.0426
Sep 21, 2021 $0.0218
Sep 22, 2021 $0.0205
Sep 23, 2021 $0.0245
4 days before -100.00%
4 days after 0%
On release day 0%
Change in period -42.49%
Sep 30, 2019
Release date Nov 14, 2019
Price on release $
EPS estimate -
EPS actual -$0.330
Date Price
Sep 20, 2021 $0.0426
Sep 21, 2021 $0.0218
Sep 22, 2021 $0.0205
Sep 23, 2021 $0.0245
4 days before -100.00%
4 days after 0%
On release day 0%
Change in period -42.49%

Adynxx Earnings History

Earnings Calendar

FAQ

What is the ADYX price-to-earnings (P/E) ratio?
ADYX P/E ratio as of Nov 17, 2025 (TTM) is -0.00000974890103.

What are Adynxx Inc.'s retained earnings?
On its balance sheet, Adynxx Inc. reported retained earnings of $0 for the latest quarter ending Sep 30, 2019.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT ADYNXX INC.
Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of fo...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE